Menu

Myeloma Highlights from ASH 2015 Conference

| Jack Aiello

This is my tenth year attending ASH (American Society of Hematology), where 25,000 attendees from all over the world (hematologists/oncologists, lab researchers, oncology nurses, scientists & 300 pharma companies) present the latest research results during both oral presentations (1000) as well as on posters (3000) that cover all blood cancers. This year there were nearly […]

SUMMARY of ASH 2015

| Jack Aiello

Before presenting my ASH summary, I’ll mention a late-breaking abstract presentation that I attended this morning.  Maybe you’ve already heard about CAR-T therapy (Chimeric Antigen Receptor for T-cells).  This very new immunology treatment removes T-cells from the patient and re-engineers and re-infuses them in the patient, so that these CAR-T cells recognize and destroy cancer […]

Day 3 at ASH 2015

| Jack Aiello

Today was the final full day of ASH, and I attended oral presentations this morning beginning at 7 a.m.  With all the excitement about recent multiple myeloma drug approvals last month, I wondered what might be next.  The answer might be a drug called Pembrolizumab (Pembro), an anti PD-1 antibody that is also referred to […]

Day 2 at ASH 2015

| Jack Aiello

Today’s events began with 7:30 am oral presentations on multiple myeloma therapies (excluding transplants, which came later in the afternoon). Highlights from the oral presentation during the day included: Revilmid®/VELCADE®/dexamethasone (RVd) + Panobinostat (Pano) for newly diagnosed patients (remember, Pano is only approved for relapsed patients) demonstrated a 46% near complete response (nCR) / complete […]

Day 1 at ASH 2015

| Jack Aiello

Today was a very long but exciting day at ASH.  It began with a 6 am working breakfast of the IMF’s International Myeloma Working Group (IMWG) that consists of nearly 200 myeloma experts from around the world. From 2003-2015, IMWG has produced 22 written Guidelines covering various treatment topics and has 7 more in review: […]

SYMPOSIUM Day at ASH 2015

| Jack Aiello

December 4th is actually the day before ASH officially begins, often called “Symposium” day. Today, my first session was a meeting of the IMF’s Global Myeloma Action Network (GMAN). This organization started three years ago and focuses on issues such as awareness, access, and education in other countries. We share best practices such as fundraising […]

Teaching You to Become Your Own Best Patient Advocate

| Jack Aiello

I’m off to Orlando, site of this year’s American Society of Hematology (ASH) conference. ASH is all about blood cancers (leukemia, lymphoma, multiple myeloma) and there are nearly 800 posters presented on myeloma alone. I’m so grateful to the International Myeloma Foundation (IMF) and their sponsors for sending me, and I look forward to blogging […]